Abstract
We found a unique property of E. coli purine nucleoside phosphorylases to selectively perform the arsenolysis reaction of ribonucleosides in their active site without affecting β-D-arabinonucleosides. In the synthesis of modified β-D-arabinonucleosides from the corresponding ribonucleosides, the catalytical amount of sodium arsenate in the transglycosylation reaction provided a 95 to 98% conversion rate. Such an approach was shown to simplify the composition of the reaction mixtures and facilitate the isolation of the target nucleosides, particularly, vidarabine, fludarabine, and nelarabine.
Similar content being viewed by others
Abbreviations
- Ara-A:
-
9-(β-D-arabinofuranosyl)adenine (vidarabin)
- Ara-Basem :
-
arabinonucleoside modified at the purine base
- Ara-U:
-
1-(β-D-arabinofuranosyl)uracil
- D-Ara1αP :
-
1-α-D-phosphoro-D-arabinose
- Bm :
-
modified purine base
- F-Ade:
-
2-fluoroadenine
- F-Ado:
-
2-fluoroadenosine
- Flud:
-
2fluoro-9-(β-D-arabinofuranosyl)adenine (fludarabine)
- 6OMe-Gua:
-
6-O-methylguanine
- 6-OMe-Guo:
-
6-O-methylguanosine
- Nel:
-
6-O-methyl-9-(β-D-arabinofuranosyl)guanine (nelarabine)
- PNP:
-
purine nucleoside phosphorylase
- RibBasem :
-
ribonucleoside modified at the purine base
- UP:
-
uridine phosphorylase
- Ura:
-
uracil
- Urd:
-
uridine
- NP:
-
nucleoside phosphorylase
References
Lakshman, M.K., Modified Nucleosides in Biochemistry, Biotechnology and Medicine, Herdewijn, P., Ed., Wiley-VCH, 2008.
Mikhailopulo, I.A. and Miroshnikov, A.I., Acta Naturae, 2010, vol. 2, pp. 38–61.
De Clercq, Annu. Rev. Pharmacol. Toxicol., 2011, vol. 51, pp. 1–24.
Bzowska, A., Kulikowska, E., and Shugar, D., Pharmacol. Therap., 2000, vol. 88, pp. 349–425.
Konstantinova, I.D., Antonov, K.V., Berzin, V.B., Dorofeeva, E.V., Fateev, I.V., Muzyka, I.S., and Miroshnikov, A.I., RF Patent No. 2368662, 2009.
Bokut’, S.B., Barai, V.N., and Zinchenko, A.I., Prikl. Biokhim. Mikrobiol., 1995, vol. 31, no. 3, pp. 308–310.
Kline, P.C. and Schramm, V.L., Biochemistry, 1993, vol. 32, pp. 13212–13219.
Schramm, V.L., J. Biol. Chem., 2007, vol. 282, pp. 28297–28300.
Silva, R.G., Hirschi, J.S., Ghanem, M., Murkin, A.S., and Schramm, V.L., Biochemistry, 2011, vol. 50, pp. 2701–2709.
Konstantinova, I.D., Fateev, I.V., and Miroshnikov, A.I., RF Patent No. 2480218, 2013.
Konstantinova, I.D., Fateev, I.V., Galegov, G.A., Deryabin, P.G., Botikov, A.G., Muzyka, I.S., L’vov, D.K., and Miroshnikov, A.I., Russ. J. Bioorg. Chem., 2013, vol. 39, no. 5, pp. 530–538.
Jensen, K.F. and Nygaard, P., Eur. J. Biochem., 1975, vol. 51, pp. 253–265.
Berzin, V.B., Dorofeeva, E.V., Leonov, V.N., and Miroshnikov, A.I., Russ. J. Bioorg. Chem., 2009, vol. 35, no. 2, pp. 193–196.
Mehellou, Y., Balzarini, J., and McGuigan, C., Antiviral Chem. Chemother., 2010, vol. 20, pp. 153–160.
Konstantinova, I.D., Antonov, K.V., Fateev, I.V., Miroshnikov, A.I., Stepchenko, V.A., Baranovsky, A.V., and Mikhailopulo, I.A., Synthesis, 2011, no. 10, pp. 1555–1560.
Esipov, R.S., Gurevich, A.I., Chuvikovsky, D.V., Chupova, L.A., Muravyova, T.I., and Miroshnikov, A.I., Protein Expr. Purif., 2002, vol. 24, no. 1, pp. 56–60.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © I.D. Konstantinova, I.V. Fateev, A.I. Miroshnikov, 2016, published in Bioorganicheskaya Khimiya, 2016, Vol. 42, No. 4, pp. 411–420.
Rights and permissions
About this article
Cite this article
Konstantinova, I.D., Fateev, I.V. & Miroshnikov, A.I. The arsenolysis reaction in the biotechnological method of synthesis of modified purine β-D-arabinonucleosides. Russ J Bioorg Chem 42, 372–380 (2016). https://doi.org/10.1134/S1068162016040105
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162016040105